Mutations in ribosomal protein L3 are associated with oxazolidinone resistance in staphylococci of clinical origin.
about
Potential role of tedizolid phosphate in the treatment of acute bacterial skin infectionsResistance to linezolid caused by modifications at its binding site on the ribosomeLow prevalence of Cfr-mediated linezolid resistance among methicillin-resistant Staphylococcus aureus in a Spanish hospital: case report on linezolid resistance acquired during linezolid therapy.Two novel point mutations in clinical Staphylococcus aureus reduce linezolid susceptibility and switch on the stringent response to promote persistent infection.Mechanisms of linezolid resistance among coagulase-negative staphylococci determined by whole-genome sequencing.Structural Basis for Linezolid Binding Site Rearrangement in the Staphylococcus aureus Ribosome.Draft Genome Sequence of Linezolid-Resistant Enterococcus faecalis Clinical Isolate HS0914.Whole genome analysis of linezolid resistance in Streptococcus pneumoniae reveals resistance and compensatory mutations.Mutations in 23S rRNA at the peptidyl transferase center and their relationship to linezolid binding and cross-resistance.Mechanisms of linezolid resistance in staphylococci and enterococci isolated from two teaching hospitals in Shanghai, China.Linezolid-resistant Staphylococcus aureus strain 1128105, the first known clinical isolate possessing the cfr multidrug resistance gene.Cfr-mediated linezolid-resistance among methicillin-resistant coagulase-negative staphylococci from infections of humans.Emergence of linezolid-resistant Staphylococcus aureus after prolonged treatment of cystic fibrosis patients in Cleveland, OhioInactivation of the indigenous methyltransferase RlmN in Staphylococcus aureus increases linezolid resistanceDissemination of the same cfr-carrying plasmid among methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococcal isolates in ChinaMechanisms of antibiotic resistance in enterococci.[Resistance to "last resort" antibiotics in Gram-positive cocci: The post-vancomycin era].rplC T460C identified as a dominant mutation in linezolid-resistant Mycobacterium tuberculosis strains.Rapid Acquisition of Linezolid Resistance in Methicillin-Resistant Staphylococcus aureus: Role of Hypermutation and Homologous Recombination.Transferable plasmid-mediated resistance to linezolid due to cfr in a human clinical isolate of Enterococcus faecalisComparative efficacies of human simulated exposures of tedizolid and linezolid against Staphylococcus aureus in the murine thigh infection model.Molecular epidemiology of Staphylococcus epidermidis clinical isolates from U.S. hospitalsComparative pharmacodynamics of the new oxazolidinone tedizolid phosphate and linezolid in a neutropenic murine Staphylococcus aureus pneumonia modelThe genetic environment of the cfr gene and the presence of other mechanisms account for the very high linezolid resistance of Staphylococcus epidermidis isolate 426-3147LDissecting the mechanisms of linezolid resistance in a Drosophila melanogaster infection model of Staphylococcus aureus.Susceptibility profile of methicillin-resistant Staphylococcus aureus to linezolid in clinical isolates.The oxazolidinones: past, present, and future.Current and prospective treatments for multidrug-resistant gram-positive infections.Antibiotic resistance in Enterococcus faecium clinical isolates.Linezolid Resistance in Staphylococci.Comparative activities of TR-700 (torezolid) against staphylococcal blood isolates collected in Spain.Characterization of novel conjugative multiresistance plasmids carrying cfr from linezolid-resistant Staphylococcus epidermidis clinical isolates from Italy.Investigation of Linezolid Resistance in Staphylococci and Enterococci.Mutations in the bacterial ribosomal protein l3 and their association with antibiotic resistance.Accumulation of multiple mutations in linezolid-resistant Staphylococcus epidermidis causing bloodstream infections; in silico analysis of L3 amino acid substitutions that might confer high-level linezolid resistance.Detection of a New cfr-Like Gene, cfr(B), in Enterococcus faecium Isolates Recovered from Human Specimens in the United States as Part of the SENTRY Antimicrobial Surveillance Program.Worrisome trend of new multiple mechanisms of linezolid resistance in staphylococcal clones diffused in Italy.Mechanisms of linezolid resistance among Staphylococci in a tertiary hospital.In vitro resistance studies with bacteria that exhibit low mutation frequencies: prediction of "antimutant" linezolid concentrations using a mixed inoculum containing both susceptible and resistant Staphylococcus aureus.Structure-activity relationships of diverse oxazolidinones for linezolid-resistant Staphylococcus aureus strains possessing the cfr methyltransferase gene or ribosomal mutations.
P2860
Q26853612-2EDF3EA8-3BC2-420B-BAAC-3F3DEFC36D5CQ27006772-142FDC8C-97BF-4200-9279-5A9C9ADECEF5Q31114532-0CB06267-71C6-40FD-A60F-0C781A3CE7C9Q33604815-2F3D0CC5-62E5-4F3E-8845-D75996E681C3Q33648052-AA772553-057E-46EA-8308-CA604243702CQ33654525-59E73942-E25B-460D-BF38-8D1CAF96ABC0Q34018158-07C4C198-CE50-4ACC-A8D0-9F0D58D5B33AQ34049640-1824FF5C-1F71-44C4-9393-85969D9ACE81Q34289995-0FFCE190-7776-4C75-AAF3-A5C51029A258Q34578863-805A86FC-BE51-4D47-9AA9-339CE4672292Q34596580-40D568E8-570E-40DE-B31C-5CD57B185538Q34600031-DBFE9277-0CD3-4389-9039-F6BA16B21BA0Q34737606-D35E56B9-FA36-44B6-9140-FC297A28DABDQ35005203-93424C7C-7B3A-4871-A85D-7515EC3A732EQ35607766-737C7765-50B9-45C2-9602-541009D9BECEQ35610646-B850020B-C1DF-484D-B84F-CB47B169E126Q35619094-97F4D491-FE3E-4769-A641-6CDC8F62455BQ35941267-D8F8A7CB-E3CD-431C-8BF1-6B0CEF61A212Q36018436-2CBF1A4B-A0BB-4F2D-871C-C7972C411710Q36086317-85B53564-82DE-448B-8FB8-19A1F1523C32Q36171683-3FE28A15-76CB-4394-8B5F-B5E6F6F7F45BQ36172406-4C634ED6-A87B-4789-9416-34E10491D391Q36364009-A20ECA99-5729-40D6-B619-15B3CE3D7B20Q36667049-B3470B30-2C89-45B5-83C2-BE11951E16ABQ36882517-0646FDC0-E3F2-4944-8BEC-EF05AEB5E2D3Q37668638-6FEB1578-C932-42F2-B6E0-BA0588BBD312Q37970719-715F0AF3-0430-4638-8E17-6788F4C859F7Q38123255-9B6F0B04-02FC-4A06-8B47-92E7786B10FEQ38176042-311A580B-58D4-4EA3-8C90-4BB617E365B0Q38974364-BF03AF6B-EA43-4916-8CC0-21F9387A336AQ40336550-2F164AC9-255B-4D27-9646-356ED9A8B2D6Q40425518-F7EEB7E6-B923-477B-B4D0-B314397F800DQ40616680-738A1C91-CD00-4153-A641-558B98F55008Q40676510-053B053E-7404-4DD7-9988-CBDA7B458F41Q40714805-4865223C-33BA-4522-AB52-7233AAC573C7Q41066058-3039E3CE-ABC4-4E97-8005-B0D4776B5997Q41159056-6042D830-03BF-4439-B1BD-FA6632A28A0AQ41444650-8DDAAA47-F9A8-462F-B24F-9476B6D8EDCFQ41850136-AF0EC22B-F422-407B-8FC7-EE2F2A0A44B5Q41862729-8A0F4943-FC60-44FB-865C-5BD7A1B6D6AD
P2860
Mutations in ribosomal protein L3 are associated with oxazolidinone resistance in staphylococci of clinical origin.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Mutations in ribosomal protein ...... phylococci of clinical origin.
@en
type
label
Mutations in ribosomal protein ...... phylococci of clinical origin.
@en
prefLabel
Mutations in ribosomal protein ...... phylococci of clinical origin.
@en
P2860
P356
P1476
Mutations in ribosomal protein ...... aphylococci of clinical origin
@en
P2093
Jeffrey B Locke
Mark Hilgers
P2860
P304
P356
10.1128/AAC.01032-09
P407
P50
P577
2009-10-05T00:00:00Z